BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16433192)

  • 1. In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii.
    Sader HS; Rhomberg PR; Jones RN
    J Chemother; 2005 Dec; 17(6):622-7. PubMed ID: 16433192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro bactericidal effect of a beta-lactam+aminoglycoside combination against multiresistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Roussel-Delvallez M; Wallet F; Delpierre F; Courcol RJ
    J Chemother; 1996 Oct; 8(5):365-8. PubMed ID: 8957716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
    Noel AR; Attwood M; Bowker KE; MacGowan AP; Albur M
    J Antimicrob Chemother; 2022 Apr; 77(5):1306-1312. PubMed ID: 35137096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
    J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic detection of metallo-β-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii isolated from hospitalized patients in São Luis, State of Maranhão, Brazil.
    Carvalho RM; Marques SG; Gonçalves LH; Abreu AG; Monteiro SG; Gonçalves AG
    Rev Soc Bras Med Trop; 2013; 46(4):506-9. PubMed ID: 23982101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Oie S; Fukui Y; Yamamoto M; Masuda Y; Kamiya A
    BMC Infect Dis; 2009 Aug; 9():123. PubMed ID: 19664245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
    Ling TK; Ying CM; Lee CC; Liu ZK
    Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
    J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS; Jones RN
    Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases.
    Sader HS; Rhomberg PR; Flamm RK; Jones RN; Castanheira M
    J Antimicrob Chemother; 2017 Jun; 72(6):1696-1703. PubMed ID: 28333332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria.
    Ito A; Kohira N; Bouchillon SK; West J; Rittenhouse S; Sader HS; Rhomberg PR; Jones RN; Yoshizawa H; Nakamura R; Tsuji M; Yamano Y
    J Antimicrob Chemother; 2016 Mar; 71(3):670-7. PubMed ID: 26645269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.
    Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bulgecin A as a β-lactam enhancer for carbapenem-resistant
    Skalweit MJ; Li M
    Drug Des Devel Ther; 2016; 10():3013-3020. PubMed ID: 27703329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Pires J; Siriwardena TN; Stach M; Tinguely R; Kasraian S; Luzzaro F; Leib SL; Darbre T; Reymond JL; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7915-8. PubMed ID: 26459893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains.
    Brauers J; Frank U; Kresken M; Rodloff AC; Seifert H
    Clin Microbiol Infect; 2005 Jan; 11(1):24-30. PubMed ID: 15649300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of metallo beta-lactamase production and antibiotic resistance with E-test method in pseudomonas, acinetobacter and klebsiella strains, in Turkey.
    Toraman ZA; Yakupogullari Y; Kizirgil A
    J Infect Chemother; 2004 Oct; 10(5):257-61. PubMed ID: 16163458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.